On ECHEMI
Home > Drugs > Heifei Jiulian Pharma Co., Ltd.
Heifei Jiulian Pharma Co., Ltd.
  • Founded in:

    2001-08-01
  • Country:

    China China
  • Address:

    Anhui Changfeng Shuangfeng Economic Development Zone
  • Tax NO.:

    913401217300302871
  • Registered Funds:

    1 million yuan
  • Website:

  • Email:

Related Drugs
Chlorphenamine yellow sensitive tablets
This product is a compound preparation, and its components per tablet are: diclofenac sodium 15 mg, artificial bezoar 15 mg, and chlorpheniramine maleate 2.5 mg.
Name Description Content CAS NO. Registered Holders
Diclofenac sodium

Inhibits cyclooxygenase activity, thereby blocking the conversion of arachidonic acid to prostaglandins; promotes the combination of arachidonic acid and triglycerides, reduces the concentration of free arachidonic acid in cells, and indirectly inhibits the synthesis of leukotrienes; the inhibitory effect on prostaglandin synthesis is stronger than aspirin and indomethacin, etc.

More

Inhibits cyclooxygenase activity, thereby blocking the conversion of arachidonic acid to prostaglandins; promotes the combination of arachidonic acid and triglycerides, reduces the concentration of free arachidonic acid in cells, and indirectly inhibits the synthesis of leukotrienes; the inhibitory effect on prostaglandin synthesis is stronger than aspirin and indomethacin, etc.

15mg 15307-79-6 55
Atificial Cow-bezoar

Antipyretic, analgesic, sedative, anti-inflammatory

More

Antipyretic, analgesic, sedative, anti-inflammatory

15mg 1002-00-2 2
Chlorphenamine maleate

It can counteract the allergic reaction of histamine by antagonizing H1 receptors, does not affect histamine metabolism, does not prevent the release of histamine in the body, and has M cholinergic receptor blocking and central inhibition effects

More

It can counteract the allergic reaction of histamine by antagonizing H1 receptors, does not affect histamine metabolism, does not prevent the release of histamine in the body, and has M cholinergic receptor blocking and central inhibition effects

2.5mg 113-92-8 28
Aspirin enteric-coated tablets
The main ingredient of this product is aspirin. Its chemical name is 2-(acetoxy)benzoic acid. Molecular formula: C9H8O4 Molecular weight: 180.16
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Most of it can be absorbed in the upper part of the small intestine, but enteric-coated tablets are absorbed slowly. Aspirin has a low protein binding rate, and the protein binding rate of hydrolyzed salicylates is 65% to 90%. The t1/2 is 15 to 20 minutes; the length of the t1/2 of salicylates depends on the dose and urine pH. It is about 2 to 3 hours for a small dose, more than 20 hours for a large dose, and 5 to 18 hours for repeated use. Most of it is quickly hydrolyzed into salicylates in the gastrointestinal tract, liver, and blood, and then metabolized in the liver. The metabolites are mainly salicylic acid and glucuronic acid conjugates, and a small part is oxidized to gentisic acid. The blood drug peak is reached 1 to 2 hours after a single dose. The blood drug concentration is 25 to 50 μg/ml for analgesia and antipyretic; 150 to 300 μg/ml for anti-rheumatic and anti-inflammatory. For patients who take large doses of drugs for a long time, because the main metabolic pathway of the drug is saturated, a slight increase in dose can lead to a large change in blood drug concentration. It is excreted from the kidneys as bound metabolites and free salicylic acid. When the dosage is large, the excretion of unmetabolized salicylic acid increases. The pH value of urine affects the excretion rate. In alkaline urine, the excretion rate is accelerated and the amount of free salicylic acid increases, while in acidic urine, the opposite is true.

More

Most of it can be absorbed in the upper part of the small intestine, but enteric-coated tablets are absorbed slowly. Aspirin has a low protein binding rate, and the protein binding rate of hydrolyzed salicylates is 65% to 90%. The t1/2 is 15 to 20 minutes; the length of the t1/2 of salicylates depends on the dose and urine pH. It is about 2 to 3 hours for a small dose, more than 20 hours for a large dose, and 5 to 18 hours for repeated use. Most of it is quickly hydrolyzed into salicylates in the gastrointestinal tract, liver, and blood, and then metabolized in the liver. The metabolites are mainly salicylic acid and glucuronic acid conjugates, and a small part is oxidized to gentisic acid. The blood drug peak is reached 1 to 2 hours after a single dose. The blood drug concentration is 25 to 50 μg/ml for analgesia and antipyretic; 150 to 300 μg/ml for anti-rheumatic and anti-inflammatory. For patients who take large doses of drugs for a long time, because the main metabolic pathway of the drug is saturated, a slight increase in dose can lead to a large change in blood drug concentration. It is excreted from the kidneys as bound metabolites and free salicylic acid. When the dosage is large, the excretion of unmetabolized salicylic acid increases. The pH value of urine affects the excretion rate. In alkaline urine, the excretion rate is accelerated and the amount of free salicylic acid increases, while in acidic urine, the opposite is true.

50-78-2 35
Piracetam Tablets
Main ingredients: The main ingredient of this product is: Piracetam. Its chemical name is: 2-oxidation-1-pyrrolidinyl acetamide. Molecular formula: C6H10N2O2 Molecular weight: 142.16.
Name Description Content CAS NO. Registered Holders
Piracetam

This product is a brain metabolism improving drug, which is a cyclic derivative of g-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote ATP in the brain, promote acetylcholine synthesis and positively enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

More

This product is a brain metabolism improving drug, which is a cyclic derivative of g-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote ATP in the brain, promote acetylcholine synthesis and positively enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

7491-74-9 24
Diclofenac Sodium Enteric-Coated Tablets
The main ingredient of this product is: diclofenac sodium.
Name Description Content CAS NO. Registered Holders
Diclofenac sodium

See the instruction manual for details

More

See the instruction manual for details

15307-79-6 55
Oyster calcium carbonate tablets
The main component of this product is calcium compounds mainly composed of calcium carbonate and calcium hydroxide, which are obtained by calcining oyster shells at high temperature.
Name Description Content CAS NO. Registered Holders
Calcium carbonate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

471-34-1 43
Calcium hydroxide

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

1305-62-0 5
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.